Ziegler SI - Search Results

1

Reproducibility of metabolic measurements in malignant tumors using FDG PET.

Weber WA, Ziegler SI, Thödtmann R, Hanauske AR, Schwaiger M. Weber WA, et al. Among authors: ziegler si. J Nucl Med. 1999 Nov;40(11):1771-7. J Nucl Med. 1999. PMID: 10565769 Free article. Clinical Trial.

2

Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry.

Haberkorn U, Strauss LG, Reisser C, Haag D, Dimitrakopoulou A, Ziegler S, Oberdorfer F, Rudat V, van Kaick G. Haberkorn U, et al. J Nucl Med. 1991 Aug;32(8):1548-55. J Nucl Med. 1991. PMID: 1869977 Free article.

3

Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas.

Laubenbacher C, Saumweber D, Wagner-Manslau C, Kau RJ, Herz M, Avril N, Ziegler S, Kruschke C, Arnold W, Schwaiger M. Laubenbacher C, et al. J Nucl Med. 1995 Oct;36(10):1747-57. J Nucl Med. 1995. PMID: 7562038 Free article.

4

Differential diagnosis of CNS lesions in AIDS patients by FDG-PET.

Villringer K, Jäger H, Dichgans M, Ziegler S, Poppinger J, Herz M, Kruschke C, Minoshima S, Pfister HW, Schwaiger M. Villringer K, et al. J Comput Assist Tomogr. 1995 Jul-Aug;19(4):532-6. doi: 10.1097/00004728-199507000-00004. J Comput Assist Tomogr. 1995. PMID: 7622678

5

Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy.

Haberkorn U, Strauss LG, Dimitrakopoulou A, Seiffert E, Oberdorfer F, Ziegler S, Reisser C, Doll J, Helus F, van Kaick G. Haberkorn U, et al. J Nucl Med. 1993 Jan;34(1):12-7. J Nucl Med. 1993. PMID: 8418251 Free article.

6

Deactivation of human visual cortex during involuntary ocular oscillations. A PET activation study.

Wenzel R, Bartenstein P, Dieterich M, Danek A, Weindl A, Minoshima S, Ziegler S, Schwaiger M, Brandt T. Wenzel R, et al. Brain. 1996 Feb;119 ( Pt 1):101-10. doi: 10.1093/brain/119.1.101. Brain. 1996. PMID: 8624674

7

Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose.

Avril N, Dose J, Jänicke F, Bense S, Ziegler S, Laubenbacher C, Römer W, Pache H, Herz M, Allgayer B, Nathrath W, Graeff H, Schwaiger M. Avril N, et al. J Clin Oncol. 1996 Jun;14(6):1848-57. doi: 10.1200/JCO.1996.14.6.1848. J Clin Oncol. 1996. PMID: 8656253

8

Quantitative assessment of myocardial perfusion: is it of clinical relevance?

Stollfuss JC, Kosa I, Ziegler S, Schwaiger M. Stollfuss JC, et al. Q J Nucl Med. 1996 Mar;40(1):76-84. Q J Nucl Med. 1996. PMID: 8681016 Review.

9

Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.

Avril N, Dose J, Jänicke F, Ziegler S, Römer W, Weber W, Herz M, Nathrath W, Graeff H, Schwaiger M. Avril N, et al. J Natl Cancer Inst. 1996 Sep 4;88(17):1204-9. doi: 10.1093/jnci/88.17.1204. J Natl Cancer Inst. 1996. PMID: 8780629

10

Scintigraphic evaluation of cardiac autonomic innervation.

Münch G, Ziegler S, Nguyen N, Hartmann F, Watzlowik P, Schwaiger M. Münch G, et al. J Nucl Cardiol. 1996 May-Jun;3(3):265-77. doi: 10.1016/s1071-3581(96)90040-9. J Nucl Cardiol. 1996. PMID: 8805746 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

226 results

Search Page

Filters